M H Freedman|E F Saunders - JoVE Visualize

Showing results (101-110 of 160) with videos related to

Pageof 16

Sort By:

Clinical Pharmacology and Therapeutics|April 1, 1990

Comparison of deferoxamine pharmacokinetics between asymptomatic thalassemic children and those exhibiting severe neurotoxicityY Bentur, G Koren, A Tesoro, et al.

Blood|April 1, 1987

The regulatory role of interleukin 2-responsive T lymphocytes on human marrow granulopoiesisZ Estrov, C Roifman, G Mills, et al.

Nephron|January 1, 1981

Ribonuclease activity in renal failure. Evidence for toxicityE Z Rabin, D Algom, M H Freedman, et al.

Blood|September 1, 1984

Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferationH M Lederman, A Cohen, J W Lee, et al.

Blood|December 1, 1985

Separation of lymphoid and myeloid blasts in the mixed blast crisis of chronic myelogenous leukemia: no evidence for Ig gene rearrangement in CALLA-positive blastsK Ha, M H Freedman, A Hrincu, et al.

Clinical and Laboratory Haematology|January 1, 1988

A variant form of Bernard-Soulier syndrome: mild haemostatic defect associated with partial platelet GPIb deficiencyM C Stevens, V S Blanchette, M H Freedman, et al.

Journal of Pediatric Hematology/Oncology|December 22, 1999

Juvenile myelomonocytic leukemia and Noonan syndromeK Choong, M H Freedman, D Chitayat, et al.

Gastroenterology|December 1, 1996

Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expressionD R Mack, G G Forstner, M Wilschanski, et al.

Clinical Pediatrics|February 25, 1998

Efficacy of amlodipine in pediatric bone marrow transplant patientsS Khattak, J W Rogan, E F Saunders, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1986

Selective protection of tubercidin toxicity by nitrobenzyl thioinosine in normal tissues but not in human neuroblastoma cellsC Kaplinsky, H Yeger, Z Estrov, et al.

Pageof 16

Showing results (101-110 of 160) with videos related to

Sort By:

Pageof 16

Clinical Pharmacology and Therapeutics|April 1, 1990

Comparison of deferoxamine pharmacokinetics between asymptomatic thalassemic children and those exhibiting severe neurotoxicityY Bentur, G Koren, A Tesoro, et al.

Blood|April 1, 1987

The regulatory role of interleukin 2-responsive T lymphocytes on human marrow granulopoiesisZ Estrov, C Roifman, G Mills, et al.

Nephron|January 1, 1981

Ribonuclease activity in renal failure. Evidence for toxicityE Z Rabin, D Algom, M H Freedman, et al.

Blood|September 1, 1984

Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferationH M Lederman, A Cohen, J W Lee, et al.

Blood|December 1, 1985

Separation of lymphoid and myeloid blasts in the mixed blast crisis of chronic myelogenous leukemia: no evidence for Ig gene rearrangement in CALLA-positive blastsK Ha, M H Freedman, A Hrincu, et al.

Clinical and Laboratory Haematology|January 1, 1988

A variant form of Bernard-Soulier syndrome: mild haemostatic defect associated with partial platelet GPIb deficiencyM C Stevens, V S Blanchette, M H Freedman, et al.

Journal of Pediatric Hematology/Oncology|December 22, 1999

Juvenile myelomonocytic leukemia and Noonan syndromeK Choong, M H Freedman, D Chitayat, et al.

Gastroenterology|December 1, 1996

Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expressionD R Mack, G G Forstner, M Wilschanski, et al.

Clinical Pediatrics|February 25, 1998

Efficacy of amlodipine in pediatric bone marrow transplant patientsS Khattak, J W Rogan, E F Saunders, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1986

Selective protection of tubercidin toxicity by nitrobenzyl thioinosine in normal tissues but not in human neuroblastoma cellsC Kaplinsky, H Yeger, Z Estrov, et al.

Pageof 16